SEC Form 4 · accession 0001179110-17-006246
Traws Pharma, Inc. · TRAW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ramesh Kumar
Officer — President and CEO · Director
Period of report
Apr 26, 2017
Accepted (ET)
Apr 28, 2017 · 3:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001130598
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 26, 2017 | P | 23,810 | $2.10 | A | 102,227 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F137,510 shares are held by the Ramesh Kumar 2012 Trust, of which the reporting person is a trustee.